Barclays PLC Sells 626,102 Shares of agilon health, inc. (NYSE:AGL)

Barclays PLC trimmed its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 50.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 602,850 shares of the company's stock after selling 626,102 shares during the quarter. Barclays PLC owned 0.15% of agilon health worth $1,146,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Symphony Financial Services Inc. lifted its holdings in agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock worth $44,000 after acquiring an additional 7,058 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Oak Thistle LLC acquired a new position in shares of agilon health in the 4th quarter valued at approximately $25,000. Ieq Capital LLC bought a new stake in agilon health during the 4th quarter worth approximately $26,000. Finally, Blair William & Co. IL raised its holdings in agilon health by 6.4% during the 4th quarter. Blair William & Co. IL now owns 254,759 shares of the company's stock worth $484,000 after buying an additional 15,409 shares during the period.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on AGL shares. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Royal Bank of Canada boosted their price target on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a report on Wednesday, February 26th. JMP Securities reiterated a "market perform" rating on shares of agilon health in a report on Monday, April 28th. Finally, Citigroup upgraded agilon health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $3.25 to $5.00 in a research note on Friday, April 25th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $4.81.

agilon health Stock Performance

Shares of AGL opened at $4.16 on Monday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a 50-day moving average of $4.23 and a 200-day moving average of $3.16. The company has a market cap of $1.72 billion, a PE ratio of -4.43 and a beta of 0.38. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.